文献速递乳房整形与再造美容整形

SilkSurface与VelvetSurface Motiva硅胶乳房假体3年初步经验:5813例连续乳房增大术单中心体验

Preliminary 3-Year Evaluation of Experience With SilkSurface and VelvetSurface Motiva Silicone Breast Implants: A Single-Center Experience With 5813 Consecutive Breast Augmentation Cases.
PubMed 文献 · Aesthet Surg J · 2018-01-01

该回顾性单中心研究评估5813例连续乳房增大术中Motiva硅胶假体(SilkSurface纳米纹理与VelvetSurface微纹理)的安全性,2013年4月至2016年4月置入。总体并发症率0.76%,再手术率0.76%,无晚期并发症及原发性包膜挛缩;在300至499 cc体积组中SilkSurface并发症率显著低于VelvetSurface。作者认为Motiva假体并发症与再手术率极低,纳米纹理SilkSurface假体并发症少于微纹理假体。

要点

  • 5813例连续乳房增大术总体并发症率0.76%,再手术率0.76%,随访3年。
  • 无晚期并发症,无原发性包膜挛缩病例。
  • 300至499 cc体积组中SilkSurface并发症率显著低于VelvetSurface。

核心结论

  • Motiva硅胶乳房假体与极低的并发症率和再手术率相关,纳米纹理SilkSurface假体并发症少于微纹理假体。

研究设计与样本

  • 回顾性研究,纳入5813例连续乳房增大术病例,评估SilkSurface(纳米纹理)与VelvetSurface(微纹理)两种假体,假体置入时间为2013年4月至2016年4月。

主要发现

  • 共报告44例并发症,总体并发症率0.76%,3年间再手术率0.76%。
  • 无晚期并发症,无原发性包膜挛缩病例。
  • 未观察到因假体置入日期不同而出现并发症率差异。
  • 在假体体积300至499 cc的患者中,SilkSurface较VelvetSurface的并发症率显著更低。
  • 高级统计分析支持本研究报告的低并发症率的有效性。

关键数值与推荐

  • 总体并发症率0.76%,再手术率0.76%。
  • 在300至499 cc体积组中,SilkSurface并发症率显著低于VelvetSurface。

临床怎么用

  • 作者认为Motiva硅胶乳房假体与极低的并发症率和再手术率相关,纳米纹理SilkSurface假体并发症少于微纹理假体。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Silicone breast implants have been in use for breast augmentation for more than 50 years, but technological innovation has been lacking in implant design until recently. OBJECTIVES: This study was designed to evaluate the complication and reoperation rates following breast augmentation utilizing the Motiva silicone breast implants. METHODS: This retrospective study evaluated the safety of Motiva implants in 5813 consecutive cases of breast augmentation. Implants with two different textured surfaces were evaluated: SilkSurface (nanotextured) and VelvetSurface (micro-textured). RESULTS: Implants were placed between April 2013 and April 2016. A total of 44 complications were reported, with an overall complication rate of 0.76%, and the rate of reoperation was 0.76% over an interval of 3 years. There were no late complications and no cases of primary capsular contracture. No differences in complication rates were observed because of the implant date. However, among patients who received implants 300 to 499 cc in volume, complication rates were significantly lower with SilkSurface compared with VelvetSurface implants. Advanced statistical analysis supported the validity of the low complication rate reported in this study. CONCLUSIONS: Overall, these findings suggest that Motiva silicone breast implants are associated with very low rates of complication and reoperation, and that the nano-textured SilkSurface implant is associated with fewer complications than micro-textured implants.

来源:Aesthet Surg J,查看原文。版权归原作者所有。

引用

  1. Sforza M, Zaccheddu R, Alleruzzo A, et al. Preliminary 3-Year Evaluation of Experience With SilkSurface and VelvetSurface Motiva Silicone Breast Implants: A Single-Center Experience With 5813 Consecutive Breast Augmentation Cases. Aesthet Surg J. 2018. PMID: 29040364. doi:10.1093/asj/sjx150

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。